AKT1 and cancer: Increasing evidence suggests that lncRNAs have the potential to alter glucose metabolism, primarily by effectively regulating critical glycolytic enzymes or cancer-associated signal transduction pathways such as the p53 and PI3K-Akt-mTOR pathways [122].